相关实验视频

Updated: Feb 28, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

识别和功能验证PTH2R作为肺腺癌的治疗标

Changmin Liu^1,2, Yongfu Wang^1,2, Wei Liu^1,2

¹School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

|February 27, 2026

概括

甲状腺激素2型受体 (PTH2R) 是肺腺癌 (LUAD) 的有前途的治疗点. 用黑激素准PTH2R显示出协同作用的抗瘤效应,抑制LUAD的进展.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

肺腺癌 (LUAD) 是全球癌症死亡的主要原因.
迫切需要LUAD的新型治疗点.
甲状腺激素2型受体 (PTH2R) 在LUAD中的作用目前尚不清楚.

研究的目的:

调查PTH2R作为LUAD的潜在治疗点.
为了评估PTH2R淘汰和LUAD中的黑色素的抗瘤作用.
阐明在LUAD中以PTH2R为向治疗的潜在分子机制.

主要方法:

对公共数据库 (SangerBox 3.0,UALCAN,Kaplan-Meier Plotter,TIMER) 进行综合分析,以确定PTH2R.
在体外测试 (增殖,殖民地形成,迁移,亡) 以评估抗瘤效应.
转录组分析和RT-qPCR用于识别和验证PTH2R信号通路中的关键基因.

主要成果:

在LUAD中,PTH2R被确定为具有预后价值的潜在治疗标.
抑制PTH2R和治疗黑色素显著抑制了LUAD细胞的增殖,殖民地形成和迁移,同时促进了细胞亡.
联合PTH2R淘汰和黑激素表现出协同的抗瘤效应,在PTH2R通路中验证了关键基因.

结论:

PTH2R是LUAD的一种新且有价值的治疗点.
黑色素通过向PTH2R来抑制LUAD,提供了一个潜在的精确治疗策略.
这项研究提供了实验证据和理论支持,用于开发新的LUAD治疗方法.

关键词:

这就是PTH2RR.生物信息学是一种生物信息学.家庭 B1 GPCRs 的家族.肺部腺癌的癌症.黑激素是什么意思黑激素是什么意思

更多相关视频

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...